Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-03-29 16:54:08
Reporting Period:
Filing Date:
Accepted Time:
2017-03-29 16:54:08
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1026765 Ivor Royston C/o Biocept, Inc.
5810 Nancy Ridge Drive #150
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-16 5,667 $8.76 17,294 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 34,584 fewer shares.
  2. The number of shares and purchase price shown in column 4 above are reflected on a post-split basis.
  3. The number of shares reflected in column 5 above reflects the Reporting Person's ownership as of March 29, 2017.